ANAPHASE NEOPTIDE serum - Efficacy and tolerability on chronic hair loss in adults used alone, in combination or as a relay to treatments
ANAPHASE NEOPTIDE serum - Efficacy and tolerability on chronic hair loss in adults used alone, in combination or as a relay to treatments
Status
Status :
Completed
Type of study
Post-marketing study
Min. Age
18
Years old
Max. Age
93
Years old
Gender
All
Brief summary
The objectives of this study were to evaluate the tolerability and the perceived efficacy of the ANAPHASE NEOPTIDE serum in chronic hair loss (hair loss lasting more than 6 months).
The subjects' hair and scalp were evaluated during 2 dermatological consultations spaced 3 months apart.
Field of application :
Dermatology
Target :
Hair loss
Dermo-cosmetic product :
ANAPHASE NEOPTIDE serum
Brand :
Ducray
Start Date :
September 2024
End Date :
July 2025
Number of subjects :
1676
Countries :
French overseas territories
Germany
Greece
Italy
Ivory Coast
Morocco
Saudi Arabia
Senegal
South Korea
Spain
Tunisia
United Arab Emirates
Venezuela
Study ID :
DU-RV4986A-2023-01